Frontlight ResearchEarly access
CompletedNo phase
Effectiveness of Hemi- Versus Total Shoulder Arthroplasty Using Implants of the "Epoca" System
Key facts
- Who runs it
- AO Innovation Translation Center
- Where
- Austria, Germany, and Sweden4 sites in 3 countriesChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 76 people enrolled
- Started
- Sept 2011
- Ended
- Jun 2024
- Type of study
- Interventional, 2 groups
- Treatments tested
- Hemiarthroplasty
- Total arthroplasty
- Record updated
- 1 July 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- Age 18 years and older
- Primary or secondary omarthrosis (eg, rheumatoid arthritis, avascular head necrosis)
- Glenoid morphologic type A1, A2 or B1 according to Walch
- Ability to understand the content of the patient information / informed consent form and to participate in the clinical investigation
- Written informed consent
Who cannot take part
- Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study; Intraoperative:
- Intraoperative decision to use implants other than Epoca
- Patients with a severe systemic disease: class III-IV according to the American Society of Anaesthesiologists physical status classification (ASA)
- Preoperative:
- Posttraumatic omarthrosis
- Biconcave aspect of glenoid (Walch type B2)
- Retroversion of glenoid more than 25° (Walch type C)
- "Epoca Reko" prosthesis
- Humerus fractures
- Substance abuse that would preclude reliable assessment
- Pregnancy
- Prisoners
- Full thickness tear of rotator cuff
- Indication for hemiarthroplasty only
- Indication for total arthroplasty only
Where is this trial?
It has sites in 3 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
The clinical question on whether or not to replace the glenoid component in patients with a degenerative shoulder disease, has not been answered yet in a randomized study with enough statistical power. In this study, patients are randomly allocated to a treatment with a hemi- or total shoulder arthroplasty using implants of the Epoca system. The primary objective is the comparison of pain and function between the treatment groups after 5 years using the Constant score.
The 2 groups in the trial
- HemiarthroplastyOther group
Patients are treated with hemi shoulder arthroplasty with CE marked medical devices of the Epoca system.
- Total arthroplastyOther group
Patients are treated with total shoulder arthroplasty with CE marked medical devices of the Epoca system.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Randomized Multicenter Study Comparing the Effectiveness of Hemi Versus Total Shoulder Arthroplasty in Patients With a Degenerative Joint Disease
- Record updated
- 1 July 2024